Characterization of the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of APR-TD011 ® (RLF-TD011®) Spray Solution
Condition:   Cutaneous T Cell Lymphoma Intervention:   Combination Product: APR-TD011 (RLF-TD011) Sponsor:   Northwestern University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2023 Category: Research Source Type: clinical trials